BGI Australia

Due to BGI's growing presence and influence in the world, BGI Australia was established in August 2016 to support its growth in the Oceanian region. Its office is located on level 6 in the prestigious QIMR Berghofer Medical Research Institute in Herston, Brisbane, Queensland.
The subsidiary of the world's largest genomics organisation headquartered in China with leading gene sequencing platform and superb sequencing and bioinformatics analysis capability, BGI Australia is BGI’s strategic research hub for the Asia Pacific region.
Dedicated to facilitating cutting-edge research in healthcare, agriculture, environment and other related areas, BGI Australia is continuously seeking collaborative opportunities across ANZ region to pursue scientific excellence by incorporating existing resources to contribute to the vision of using genomics to benefit the whole mankind.

BGI Australia Laboratory, which is BGI’s first southern hemisphere genomics laboratory, was launched in May 2017, unveiling of its cutting-edge sequencer's debut in this part of the world. Being a subsidiary of the world's largest genomic organisation with leading gene sequencing platform and superb genome sequencing and bioinformatics analysis capability, BGI Australia is devoted to facilitating cutting-edge research in the areas of healthcare, agriculture and environment.

BGI Australia, under BGI Group, has established collaborations with leading research institutions such as QIMR Berghofer Medical Research Institute, CSIRO, the University of Queensland, Griffith University and James Cook University to carry out scientific research and innovative projects in relation to human medicine, health science, sports science, marine science, biodiversity, agriculture and aquaculture. BGI Australia has been undergoing strategic discussions with universities and various organisations regarding future opportunities and partnerships.

Strategic Focus

Collaborating with Australian organisations, to advance research and discoveries in genomics, medical health, agriculture and biodiversity.
Establishing a centralised platform to provide technology transfer, training, services and industry incubation to the community.
Providing sequencing systems, analysis tools and services to healthcare providers to promote Australian’s public well-being in areas of reproductive health, cancer, rare diseases, infectious diseases etc.
Developing agriculture and aquaculture with advanced molecular breeding technology and agricultural-genomics-related research, to promote sino-Australia agribusiness partnerships.

BGI Australia opened a genetic sequencing laboratory in May 2017 which is also BGI’s first genomics laboratory located in the southern hemisphere. The laboratory hosts BGI’s proprietary next generation sequencing platform including BGISEQ-500 (Zebra) and MGISEQ-2000 (Panda), which have also received CFDA (China Food and Drug Administration) certification recently in July 2018. The state of the art facility currently has the capacity to sequence approximately 1,800 whole genome sequencing samples or about 40,000 RNA-seq samples per year and is anticipating the addition of more sequencers to double the throughput.
Since the debut, BGI Australia Laboratory focuses on serving for diverse local research collaborations, e.g. sequencing samples for RNA-seq, Whole Genome Sequencing, Exome, ChiP-seq and Methyl-seq applications.